Up to four years of treatment with Symdeko (tezacaftor/izacaftor) is safe and effective in people with cystic fibrosis…
Articles by Lindsey Shapiro, PhD
Children with cystic fibrosis (CF) show significant differences from healthy children in the quality of their food choices and, subsequently,…
The first patient has been dosed in a Phase 1b/2 clinical trial testing WRAIR-PAM-CF1, an investigational bacteriophage therapy, in adult…
Renexxion is seeking clearance from the U.S. Food and Drug Administration (FDA) for clinical testing of the treatment candidate…
Cystic Fibrosis News Today brought you daily coverage of the latest scientific discoveries, treatment advances, and clinical trials related to…
For a small group of people with cystic fibrosis (CF), one year of treatment with Orkambi (ivacaftor/lumacaftor) improved…
A recent overall decline in lung transplant rates for adults and children with cystic fibrosis (CF) in the U.S.
Adding a school specialist to cystic fibrosis (CF) care teams could help identify educational risk factors — and provide…
High blood-sugar levels at night are associated with poorer lung function in adults, but not in children, with cystic…
Children with cystic fibrosis (CF) being treated with Orkambi (ivacaftor/lumacaftor) have distinct clinical response profiles after six months…